John Blau

897 total citations
25 papers, 661 citations indexed

About

John Blau is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, John Blau has authored 25 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Public Health, Environmental and Occupational Health and 4 papers in Oncology. Recurrent topics in John Blau's work include Biomedical Text Mining and Ontologies (3 papers), AI in cancer detection (3 papers) and Electronic Health Records Systems (3 papers). John Blau is often cited by papers focused on Biomedical Text Mining and Ontologies (3 papers), AI in cancer detection (3 papers) and Electronic Health Records Systems (3 papers). John Blau collaborates with scholars based in United States, Malaysia and Japan. John Blau's co-authors include Matthew D. Krasowski, Cory Morris, Sean Ekins, Ulysses J. Balis, Edward Kim, Mark M. Zalupski, Diane M. Simeone, Joel K. Greenson, Ronald A. Craig and Gazala Khan and has published in prestigious journals such as Clinical Cancer Research, Journal of Neurology Neurosurgery & Psychiatry and Journal of Investigative Dermatology.

In The Last Decade

John Blau

23 papers receiving 649 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Blau United States 10 213 182 97 80 57 25 661
Shashi Kant Verma India 10 83 0.4× 220 1.2× 27 0.3× 77 1.0× 76 1.3× 58 806
Amal Ahmed Mohamed Egypt 16 82 0.4× 168 0.9× 35 0.4× 57 0.7× 73 1.3× 109 825
Anurag Verma United States 20 114 0.5× 497 2.7× 45 0.5× 37 0.5× 26 0.5× 65 1.3k
Yanhui Wu China 14 77 0.4× 288 1.6× 46 0.5× 40 0.5× 34 0.6× 52 659
Yong Tang China 20 283 1.3× 434 2.4× 34 0.4× 47 0.6× 34 0.6× 60 1.1k
Stefan Buchholz Germany 24 416 2.0× 314 1.7× 347 3.6× 32 0.4× 18 0.3× 82 1.4k
Fangfang Liu China 20 208 1.0× 145 0.8× 29 0.3× 49 0.6× 36 0.6× 93 1.1k
Yen‐Hao Chen Taiwan 17 184 0.9× 211 1.2× 57 0.6× 71 0.9× 7 0.1× 84 1.0k
Alexander Bauer Germany 16 274 1.3× 340 1.9× 21 0.2× 35 0.4× 21 0.4× 65 1.2k

Countries citing papers authored by John Blau

Since Specialization
Citations

This map shows the geographic impact of John Blau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Blau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Blau more than expected).

Fields of papers citing papers by John Blau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Blau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Blau. The network helps show where John Blau may publish in the future.

Co-authorship network of co-authors of John Blau

This figure shows the co-authorship network connecting the top 25 collaborators of John Blau. A scholar is included among the top collaborators of John Blau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Blau. John Blau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krueger, James G., Sandra Garcet, Sanjay Kumar, et al.. (2024). 265 Modulation of disease-central cytokine pathways with TAK-279, a highly selective oral tyrosine kinase 2 (TYK2) inhibitor, defines clinical response in patients with psoriasis. Journal of Investigative Dermatology. 144(8). S46–S46. 1 indexed citations
2.
Rogers, Kai J., John Blau, & Matthew D. Krasowski. (2024). Evaluating the utility and challenges associated with “unknown” and fictional patients in the electronic medical record. Academic Pathology. 11(3). 100141–100141.
3.
4.
Krasowski, Matthew D., et al.. (2021). Teaching Pathology in an Integrated Preclinical Medical School Curriculum and Adaptations to COVID-19 Restrictions. Academic Pathology. 8. 2466114729–2466114729. 8 indexed citations
5.
Chopra, Saurav, Aayushi Garg, Annette J. Schlueter, & John Blau. (2021). Nationwide practices in the use of central venous catheters for therapeutic plasma exchange in the inpatient setting. Journal of Clinical Apheresis. 36(6). 790–796. 3 indexed citations
6.
Ouillette, Peter, Christopher L. Williams, John Blau, et al.. (2020). Display Characteristics and Their Impact on Digital Pathology: A Current Review of Pathologists’ Future “Microscope”. Journal of Pathology Informatics. 11(1). 23–23. 24 indexed citations
7.
Blau, John, et al.. (2020). Frozen Section Quality Assurance. American Journal of Clinical Pathology. 156(3). 461–470. 13 indexed citations
8.
Imborek, Katherine L., et al.. (2017). Preferred Names, Preferred Pronouns, and Gender Identity in the Electronic Medical Record and Laboratory Information System: Is Pathology Ready?. Journal of Pathology Informatics. 8(1). 42–42. 24 indexed citations
9.
Blau, John, Nitin J. Karandikar, Emily Fuller, et al.. (2017). Implementation of Epic Beaker Anatomic Pathology at an Academic Medical Center. Journal of Pathology Informatics. 8(1). 47–47. 9 indexed citations
10.
Krasowski, Matthew D., et al.. (2016). Implementation of Epic Beaker Clinical Pathology at an academic medical center. Journal of Pathology Informatics. 7(1). 7–7. 22 indexed citations
11.
Krasowski, Matthew D., et al.. (2015). Use of a data warehouse at an academic medical center for clinical pathology quality improvement, education, and research. Journal of Pathology Informatics. 6(1). 45–45. 19 indexed citations
12.
Kim, Edward, Vaibhav Sahai, Ethan V. Abel, et al.. (2014). Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma. Clinical Cancer Research. 20(23). 5937–5945. 236 indexed citations
13.
Krasowski, Matthew D., et al.. (2014). Cross-reactivity of steroid hormone immunoassays: clinical significance and two-dimensional molecular similarity prediction. BMC Clinical Pathology. 14(1). 33–33. 148 indexed citations
14.
Krasowski, Matthew D., et al.. (2014). Autoverification in a core clinical chemistry laboratory at an academic medical center. Journal of Pathology Informatics. 5(1). 13–13. 73 indexed citations
15.
Blau, John. (2013). Outlook Cloudy for Germany's Solar R&D. Research-Technology Management. 56(2). 4. 2 indexed citations
16.
Blau, John. (2012). Science Still Not a "Girl Thing" in Europe. Research-Technology Management. 55(6). 9. 1 indexed citations
17.
Blau, John. (2011). German CTO Embraces and Exploits Change. Research-Technology Management. 54(3). 2. 1 indexed citations
18.
Blau, John. (2011). Building the Smart Grid in Europe. Research-Technology Management. 54(2). 2. 1 indexed citations
19.
Blau, John. (1982). Headache: Physiopathological and Clinical Concepts (Advances in Neurology, Vol 33). Journal of Neurology Neurosurgery & Psychiatry. 45(7). 666–667. 2 indexed citations
20.
Blau, John, et al.. (1953). The Two Sovereignties; a Study of the Relationship between Church and State.. The Journal of Philosophy. 50(23). 705–705. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026